--- title: "12 Health Care Stocks Moving In Tuesday's After-Market Session" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/281253428.md" description: "In Tuesday's after-market session, Iterum Therapeutics (ITRM) saw a significant gain of 37.0%, reaching $0.04, while Inspira Technologies Oxy (IINN) rose 11.01% to $0.5. Other gainers included Profusa (PFSA) up 9.13% to $0.55, and Omeros (OMER) up 7.96% to $11.4. Conversely, ORIC Pharmaceuticals (ORIC) fell 25.1% to $9.49, and BioAtla (BCAB) dropped 18.89% to $0.13. The Q4 earnings reports for several companies were released today, impacting stock movements." datetime: "2026-03-31T21:05:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281253428.md) - [en](https://longbridge.com/en/news/281253428.md) - [zh-HK](https://longbridge.com/zh-HK/news/281253428.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281253428.md) | [English](https://longbridge.com/en/news/281253428.md) # 12 Health Care Stocks Moving In Tuesday's After-Market Session ### Gainers - **Iterum Therapeutics** (NASDAQ:ITRM) stock increased by 37.0% to $0.04 during Tuesday's after-market session. The company's market cap stands at $3.7 million. - **Inspira Technologies Oxy** (NASDAQ:IINN) shares rose 11.01% to $0.5. The company's market cap stands at $17.1 million. The company's, FY earnings came out 3 days ago. - **Profusa** (NASDAQ:PFSA) shares moved upwards by 9.13% to $0.55. - **Lantern Pharma** (NASDAQ:LTRN) stock increased by 8.02% to $1.48. The market value of their outstanding shares is at $13.8 million. The company's, Q4 earnings came out yesterday. - **Omeros** (NASDAQ:OMER) stock moved upwards by 7.96% to $11.4. The company's market cap stands at $695.5 million. As per the news, the Q4 earnings report came out today. - **Jin Medical International** (NASDAQ:ZJYL) shares rose 7.42% to $2.17. The company's market cap stands at $288.0 million. ### Losers - **ORIC Pharmaceuticals** (NASDAQ:ORIC) stock fell 25.1% to $9.49 during Tuesday's after-market session. The market value of their outstanding shares is at $1.3 billion. - **BioAtla** (NASDAQ:BCAB) stock fell 18.89% to $0.13. The market value of their outstanding shares is at $12.7 million. As per the news, the Q4 earnings report came out today. - **Virax Biolabs Group** (NASDAQ:VRAX) stock decreased by 10.37% to $0.2. The market value of their outstanding shares is at $1.2 million. - **Co-Diagnostics** (NASDAQ:CODX) stock fell 10.22% to $1.67. The company's market cap stands at $3.5 million. As per the news, the Q4 earnings report came out today. - **Lipocine** (NASDAQ:LPCN) shares decreased by 9.27% to $7.25. The market value of their outstanding shares is at $55.3 million. - **Imunon** (NASDAQ:IMNN) stock decreased by 9.19% to $2.67. The company's market cap stands at $9.7 million. As per the press release, Q4 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### 相關股票 - [Inspira Tech OXY (IINN.US)](https://longbridge.com/zh-HK/quote/IINN.US.md) - [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md) - [Iterum Therap (ITRM.US)](https://longbridge.com/zh-HK/quote/ITRM.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Profusa (PFSA.US)](https://longbridge.com/zh-HK/quote/PFSA.US.md) - [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Omeros (OMER.US)](https://longbridge.com/zh-HK/quote/OMER.US.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [ITERUM THERAPEUTICS PLC (ITRMF.US)](https://longbridge.com/zh-HK/quote/ITRMF.US.md) ## 相關資訊與研究 - [OMER S.p.A.: Resilient Fundamentals and Structural Growth Support Buy Rating Despite Softer FY26 Outlook](https://longbridge.com/zh-HK/news/281649119.md) - [Iterum Therapeutics Files Wind Up Petition; Shares Shoot In Pre-market](https://longbridge.com/zh-HK/news/280999380.md) - [Omeros Turns Corner With Novo Deal, YARTEMLEA Launch](https://longbridge.com/zh-HK/news/281666535.md) - [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-HK/news/281174211.md) - [Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS](https://longbridge.com/zh-HK/news/281282968.md)